Qiagen, TIGR, and Montefiore Pen Genotyping Agreement | GenomeWeb

NEW YORK, March 14 – Genotyping technology company Qiagen Genomics said Wednesday it had reached a research and licensing agreement with The Institute for Genomic Research and the Montefiore Medical Center to conduct an association study of SNPs in Mycobaterium tuberculosis , the bacterium that causes tuberculosis. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.